Literature DB >> 33389361

Inter-vendor comparison of left atrial strain using layer specific strain analysis.

Aaisha Ferkh1,2,3, Luke Stefani2,3, Siddharth J Trivedi1,2,3, Paula Brown2,3, Karen Byth1,3,4, Faraz Pathan3,5,6, Liza Thomas7,8,9,10,11.   

Abstract

Left atrial strain (LAS) on transthoracic echocardiogram (TTE) is increasingly recognised to have clinical utility in cardiovascular disease. Differences in LAS measurements between vendors remains a barrier for clinical use. We sought to compare LAS between two commonly used software platforms; the layer-specific endocardial and mid-myocardial measurements of LAS on General Electric (GE) Echopac were compared to TomTec strain. LAS was measured in 88 individuals with no previous cardiac history and 40 paroxysmal AF (PAF) patients, in sinus rhythm at TTE. Conventionally, LAS measured using GE Echopac is mid-myocardial strain (GE-mid); additionally, endocardial (GE-endo) LAS was evaluated. Both LAS measurements by GE were compared to TomTec-Arena (v2.30.02) measurements. Reservoir (ƐR), contractile (ƐCT) and conduit (ƐCD) phasic strain were evaluated. Both GE-mid and GE-endo LAS correlated well with TomTec LAS. On Bland-Altman analysis, GE-mid LAS measurements were systematically lower than TomTec LAS (ƐR: mean difference (MD) - 6.08%, limits of agreement (LOA) - 12%, 0%, ƐCT: MD - 0.8%, LOA - 7%, 5%, ƐCD: MD - 5.2% LOA - 12%, 1%). GE-endo LAS demonstrated no systematic difference from TomTec LAS, but had wider limits of agreement (ƐR: MD 0.41%, LOA - 7%, 8%, ƐCT: MD 0.50%, LOA - 6%, 7%, ƐCD: MD - 0.08%, LOA - 7%, 7%). ƐR had the best reproducibility. Mid-myocardial LAS, routinely evaluated by GE Echopac software, systematically underestimates LAS compared to TomTec. Using GE endocardial LAS eliminated this bias, but introduced greater variation between measurements. Serial measurements of LAS should therefore be performed on the same vendor system.

Entities:  

Keywords:  Echocardiography; Intervendor; Left atrial strain; Multilayer strain; Speckle-tracking

Year:  2021        PMID: 33389361     DOI: 10.1007/s10554-020-02114-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  2 in total

1.  Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study.

Authors:  Jihoon Kim; Danbee Kang; Hyejeong Park; Minwoong Kang; Taek Kyu Park; Joo Myung Lee; Jeong Hoon Yang; Young Bin Song; Jin-Ho Choi; Seung-Hyuk Choi; Hyeon-Cheol Gwon; Eliseo Guallar; Juhee Cho; Joo-Yong Hahn
Journal:  Eur Heart J       Date:  2020-10-01       Impact factor: 29.983

2.  The left atrial function index: a rhythm independent marker of atrial function.

Authors:  Liza Thomas; Michelle Hoy; Karen Byth; Nelson B Schiller
Journal:  Eur J Echocardiogr       Date:  2007-08-07
  2 in total
  1 in total

1.  Incremental Prognosis by Left Atrial Functional Assessment: The Left Atrial Coupling Index in Patients With Floppy Mitral Valves.

Authors:  Benjamin Essayagh; Giovanni Benfari; Clémence Antoine; Joseph Maalouf; Sorin Pislaru; Prabin Thapa; Hector I Michelena; Maurice Enriquez-Sarano
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.